//
Fatima Ali-Rahmani - American Association for Cancer Research (AACR) , 2016
Therapeutic Area
Disease
Drug/Treatment
Oncology (ONC)
Solid malignancies
L-Tyrosine
Alex Chenchik - American Association for Cancer Research (AACR) , 2016
Therapeutic Area
Disease
Drug/Treatment
Oncology (ONC)
Solid malignancies
N/A
Mohammad Ali Amini - American Association for Cancer Research (AACR) , 2016
Therapeutic Area
Disease
Drug/Treatment
Oncology (ONC)
Solid malignancies
N/A
Dawei Chen - American Association for Cancer Research (AACR) , 2016
Therapeutic Area
Disease
Drug/Treatment
Oncology (ONC)
Solid malignancies
Crizotinib
Tiziana Triulzi - American Association for Cancer Research (AACR) , 2016
Therapeutic Area
Disease
Drug/Treatment
Oncology (ONC)
Solid malignancies
N/A
Leah M. Cook - American Association for Cancer Research (AACR) , 2016
Therapeutic Area
Disease
Drug/Treatment
Oncology (ONC)
Solid malignancies
N/A
Walid S. Kamoun - American Association for Cancer Research (AACR) , 2016
Therapeutic Area
Disease
Drug/Treatment
Oncology (ONC)
Solid malignancies
Docetaxel
James Ackroyd - American Association for Cancer Research (AACR) , 2016
Therapeutic Area
Disease
Drug/Treatment
Oncology (ONC)
Solid malignancies
N/A
Paul C. McDonald - American Association for Cancer Research (AACR) , 2016
Therapeutic Area
Disease
Drug/Treatment
Oncology (ONC)
Solid malignancies
Gemcitabine
Huda H. Alkhalaf - American Association for Cancer Research (AACR) , 2016
Therapeutic Area
Disease
Drug/Treatment
Oncology (ONC)
Solid malignancies
N/A
Filip Bergqvist - American Association for Cancer Research (AACR) , 2016
Therapeutic Area
Disease
Drug/Treatment
Oncology (ONC)
Solid malignancies
Alprostadil
Zachary B. Fisher - American Association for Cancer Research (AACR) , 2016
Therapeutic Area
Disease
Drug/Treatment
Oncology (ONC)
Solid malignancies
ILS-969
Molly M. Gilligan - American Association for Cancer Research (AACR) , 2016
Therapeutic Area
Disease
Drug/Treatment
Oncology (ONC)
Solid malignancies
Erlotinib hydrochloride
Shaina Sedighim - American Association for Cancer Research (AACR) , 2016
Therapeutic Area
Disease
Drug/Treatment
Oncology (ONC)
Solid malignancies
N/A
Timothy J. Zumwalt - American Association for Cancer Research (AACR) , 2016
Therapeutic Area
Disease
Drug/Treatment
Oncology (ONC)
Solid malignancies
N/A
Wen-Chien Huang - American Association for Cancer Research (AACR) , 2016
Therapeutic Area
Disease
Drug/Treatment
Oncology (ONC)
Solid malignancies
Garcinol
Caio Abner Leite - American Association for Cancer Research (AACR) , 2016
Therapeutic Area
Disease
Drug/Treatment
Oncology (ONC)
Solid malignancies
N/A
Madhu A. Lal - American Association for Cancer Research (AACR) , 2016
Therapeutic Area
Disease
Drug/Treatment
Oncology (ONC)
Solid malignancies
N/A
Jason E. McDermott - American Association for Cancer Research (AACR) , 2016
Therapeutic Area
Disease
Drug/Treatment
Oncology (ONC)
Solid malignancies
taxane
Vasileios Stathias - American Association for Cancer Research (AACR) , 2016
Therapeutic Area
Disease
Drug/Treatment
Oncology (ONC)
Solid malignancies
N/A